Results 21 to 30 of about 3,339 (149)
Effects of dutasteride and tamsulosin on penile morphology in a rodent model [PDF]
International Brazilian Journal of Urology, 2023 Purpose To evaluate the penile morphology after the isolated and combined administration of dutasteride and tamsulosin in a rodent model. Materials and Methods Forty male rats were assigned into the following groups: Control group (C, receiving ...
Marcello H. A. Da Silva +3 more
doaj +1 more source
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
BMC Musculoskeletal Disorders, 2018 Background Dutasteride is a potent inhibitor of 5-alpha reductase enzymes that reduces concentrations of dihydrotestosterone to a greater extent than finasteride. Whether this has adverse implications for bone health is unknown.
Tony Antoniou +8 more
doaj +1 more source
Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies. [PDF]
PLoS ONE, 2014 The aim of the present work was to study the in vitro/in vivo characteristics of dutasteride loaded biodegradable microspheres designed for sustained release of dutasteride over four weeks.
Xiangyang Xie +6 more
doaj +1 more source
Dutasteride and Prostate Cancer [PDF]
New England Journal of Medicine, 2010 Contains fulltext : 88812.pdf (Publisher’s version ) (Open Access)
Kiemeney, L.A.L.M., Bosland, M.C.
openaire +7 more sources
PLoS ONE, 2019 Dutasteride, a dual inhibitor of both type I and II 5α-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified.
Arang Rhie +10 more
doaj +1 more source
Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro [PDF]
Vojnosanitetski Pregled, 2016 Background/Aim. Benign prostatic hyperplasia (BPH) is one of the most common disease among males aging 50 years and more. The rise of the prevalence of BPH is related to aging, and since duration of life time period has the tendency of rising ...
Dabanović Vera +2 more
doaj +1 more source
Inhibitory Effects of Dutasteride on TLR4: An In vitro Pain Study
Iranian Journal of Allergy, Asthma and Immunology, 2022 Dutasteride was potentially proposed to control chronic pain by Toll-Like Receptor 4 (TLR4) inhibition through its effect on TLR4 expression, Myeloid differentiation primary response 88 (MyD88), Nuclear factor kappa-light-chain-enhancer of activated B ...
Leila Taheran +7 more
doaj +1 more source
Frontiers in Oncology, 2019 Background: To evaluate the efficacy of early dutasteride administration in patients with a detectable prostate-specific antigen (PSA) levels after robot-assisted radical prostatectomy (RARP).Methods: We retrospectively analyzed RARP patients whose ...
Chin-Heng Lu +7 more
doaj +1 more source
Preparation and Characterization of Dutasteride Nanoparticles as Oral Fast-Dissolving Film
مجلة كلية الطبBackground: Dutasteride, is a drug whose mechanism of action is inhibition of the enzyme 5-alpha reductase. It has been approved for use in the treatment of benign prostatic hyperplasia.
Rusul W. Kadhum +1 more
doaj +1 more source
pharma-kritik, 2004 Ein zweiter 5alpha-Reduktasehemmer zur Behandlung der benignen Prostatahyperplasie. Dutasterid hat eine ungewöhnlich lange Halbwertszeit und erscheint nach bisherigem Wissen als ähnlich wirksam wie Finasterid. Die Symptome der Prostathyperplasie werden von diesen Substanzen eher weniger gut gelindert als von Alphablockern.
openaire +1 more source